ACTR-55. TUMOR TREATING FIELDS WITH SECOND LINE TREATMENT COMPARED TO SECOND LINE TREATMENT ALONE IN PATIENTS AT FIRST RECURRENCE OF GLIOBLASTOMA – A POST HOC ANALYSIS OF THE EF-14 PHASE 3 CLINICAL TRIAL
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.